Skip to main content

Advertisement

SpringerLink
Log in

Current Status of Stem Cell Therapy in Heart Failure

  • Narrative Review
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

One of the major unsolved issues in the cardiac sciences is the problem of heart failure. Heart failure is associated with high morbidity and mortality rates. In the past two decades, various types of stem cells have been proposed as a unique method of regenerating cardiac muscle. Early successes in preclinical models as well as early nonrandomised studies raised hopes that have been belied by later trials which have often had disappointing results. To this must be added the issues arising from uncovering of poorly conducted studies with biases. This has led to much confusion and it is difficult to separate the wheat from the chaff. This short review evaluates the evidence as it stands today and examines the possibility of using regenerative methods mediated by stem cells in order to highlight the developments for general surgeons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Huffman MD, Prabhakaran D (2010) Heart failure: epidemiology and prevention in India. Natl Med J India 23(5):283–288

    PubMed  PubMed Central  Google Scholar 

  2. Prabhakaran D, Jeemon P, Roy A (2016) Cardiovascular diseases in India: current epidemiology and future directions. Circulation 133(16):1605–1620. https://doi.org/10.1161/CIRCULATIONAHA.114.008729

    Article  PubMed  Google Scholar 

  3. Orlic D, Kajstura J, Chimenti S et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701–705. https://doi.org/10.1038/35070587

    Article  CAS  PubMed  Google Scholar 

  4. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, Kajstura J, Leri A, Anversa P (2002) Chimerism of the transplanted heart. N Engl J Med 346(1):5–15. https://doi.org/10.1056/NEJMoa012081

    Article  PubMed  Google Scholar 

  5. Fuchs S, Baffour R, Zhou YF, Shou M, Pierre A, Tio FO, Weissman NJ, Leon MB, Epstein SE, Kornowski R (2001) Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37(6):1726–1732. https://doi.org/10.1016/s0735-1097(01)01200-1

    Article  CAS  PubMed  Google Scholar 

  6. Hamano K, Li TS, Kobayashi T, Hirata K, Yano M, Kohno M, Matsuzaki M (2002) Therapeutic angiogenesis induced by local autologous bone marrow cell implantation. Ann Thorac Surg 73(4):1210–1215. https://doi.org/10.1016/s0003-4975(02)03373-8

    Article  PubMed  Google Scholar 

  7. Hamano K, Nishida M, Hirata K, Mikamo A, Li TS, Harada M, Miura T, Matsuzaki M, Esato K (2001) Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 65(9):845–847. https://doi.org/10.1253/jcj.65.845

    Article  CAS  PubMed  Google Scholar 

  8. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364(9429):141–148. https://doi.org/10.1016/S0140-6736(04)16626-9

    Article  PubMed  Google Scholar 

  9. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM (2002) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009–3017

    Article  PubMed  Google Scholar 

  10. Mathiasen AB, Qayyum AA, Jørgensen E, Helqvist S, Fischer-Nielsen A, Kofoed KF, Haack-Sørensen M, Ekblond A, Kastrup J (2015) Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). Eur Heart J 36(27):1744–1753. https://doi.org/10.1093/eurheartj/ehv136

    Article  CAS  PubMed  Google Scholar 

  11. Mathiasen AB, Qayyum AA, Jørgensen E, Helqvist S, Kofoed KF, Haack-Sørensen M, Ekblond A, Kastrup J (2020) Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4-year follow-up of the MSC-HF trial. Eur J Heart Fail 22(5):884–892. https://doi.org/10.1002/ejhf.1700

    Article  CAS  PubMed  Google Scholar 

  12. Choudhury T, Mozid A, Hamshere S (2017) An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial. Eur J Heart Fail 19:138–147. https://doi.org/10.1002/ejhf

    Article  CAS  PubMed  Google Scholar 

  13. Steinho G, Nesteruk J, Wolfien M, Kundt G, Borgermann J, David R, Garbade J, Grosse J, Haverich A, Hennig H et al (2017) Cardiac function improvement and bone marrow response: outcome analysis of the randomized PERFECT phase III clinical trial of intramyocardial CD133(+) application after myocardial infarction. EBioMedicine 22:208–224

    Google Scholar 

  14. Nair V, Madan H, Sofat S et al (2015) Efficacy of stem cell in improvement of left ventricular function in acute myocardial infarction–MI3 Trial. Indian J Med Res 142(2):165–174. https://doi.org/10.4103/0971-5916.164245

    Article  PubMed  PubMed Central  Google Scholar 

  15. Chung ES, Miller L, Patel AN et al (2015) Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cellderived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial. Eur Heart J 36:2228–2238. https://doi.org/10.1093/eurheartj/ehv254

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Vrtovec B, Poglajen G, Lezaic L, Sever M, Domanovic D, Cernelc P, Socan A, Schrepfer S, Torre-Amione G, Haddad F, Wu JC (2013) Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circ Res 112:165–173. https://doi.org/10.1161/CIRCRESAHA.112.276519

    Article  CAS  PubMed  Google Scholar 

  17. Kajstura J, Rota M, Cappetta D, Ogórek B, Arranto C, Bai Y, Ferreira-Martins J, Signore S, Sanada F, Matsuda A, Kostyla J, Caballero MV, Fiorini C, D’Alessandro DA, Michler RE, del Monte F, Hosoda T, Perrella MA, Leri A, Buchholz BA, Loscalzo J, Anversa P (2012) Cardiomyogenesis in the aging and failing human heart. Circulation 126(15):1869–1881. https://doi.org/10.1161/CIRCULATIONAHA.112.118380. Retraction. In: Circulation. 2014;129(16):e466

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Oransky i, Marcus A. Harvard and the Brigham call for more than 30 retractions of cardiac stem cell research. https://www.statnews.com/2018/10/14/harvard-brigham-retractions-stem-cell/ Accessed 4/8/2021

  19. Chien K (2004) Lost in translation. Nature 428:607–608. https://doi.org/10.1038/nature02500

    Article  CAS  PubMed  Google Scholar 

  20. Nguyen PK, Rhee JW, Wu JC (2016) Adult stem cell therapy and heart failure, 2000 to 2016: a systematic review. JAMA Cardiol 1(7):831–841. https://doi.org/10.1001/jamacardio.2016.2225

    Article  PubMed  PubMed Central  Google Scholar 

  21. Nair N, Gongora E (2020) Stem cell therapy in heart failure: where do we stand today? Biochim Biophys Acta Mol Basis Dis 1866(4):165489. https://doi.org/10.1016/j.bbadis.2019.06.003

    Article  CAS  PubMed  Google Scholar 

  22. Fisher SA, Doree C, Mathur A, Taggart DP, Martin-Rendon E (2016) Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst Rev (12):Art. No.: CD007888. https://doi.org/10.1002/14651858.CD007888.pub3

  23. Anon (2017) A futile cycle in cell therapy Nat Biotechnol 35:291

  24. Steinhoff G, Nesteruk J, Wolfien M, Große J, Ruch U, Vasudevan P, Müller P (2017) Stem cells and heart disease -brake or accelerator? Adv Drug Deliv Rev 120:2–24

    Article  CAS  PubMed  Google Scholar 

  25. Broughton KM, Sussman MA (2018) Enhancement strategies for cardiac regenerative cell therapy: Focus on adult stem cells. Circ Res 123:177–187. https://doi.org/10.1161/CIRCRESAHA.118.311207

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Chopra A, Kutys ML, Zhang K, Polacheck WJ, Sheng CC, Luu RJ, Eyckmans J, Hinson JT, Seidman JG, Seidman CE, Chen CS (2018) Force generation via β-cardiac myosin, titin, and α-actinin drives cardiac sarcomere assembly from cell-matrix adhesions. Dev Cell 44(1):87-96.e5. https://doi.org/10.1016/j.devcel.2017.12.012

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Seeger T, Shrestha R, Lam CK, Chen C, McKeithan WL, Lau E, Wnorowski A, McMullen G, Greenhaw M, Lee J et al (2019) A premature termination codon mutation in MYBPC3 causes hypertrophic cardiomyopathy via chronic activation of nonsense-mediated decay. Circulation 139:799–811

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Hasan A, Soliman S, El Hajj F et al (2018) Fabrication and in vitro characterization of a tissue engineered PCL-PLLA heart valve. Sci Rep 8:8187. https://doi.org/10.1038/s41598-018-26452-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Lieshout MV, Peters G, Rutten M, Baaijens F (2006) A knitted, fibrin-covered polycaprolactone scaffold for tissue engineering of the aortic valve. Tissue Eng 12:481–487

    Article  PubMed  Google Scholar 

  30. Motta SE, Lintas V, Fioretta ES, Dijkman PE, Putti M, Caliskan E, Rodriguez Cetina Biefer H, Lipiski M, Sauer M, Cesarovic N, Hoerstrup SP, Emmert MY (2019) Human cell-derived tissue-engineered heart valve with integrated Valsalva sinuses: towards native-like transcatheter pulmonary valve replacements. NPJ Regen Med 4:14. https://doi.org/10.1038/s41536-019-0077-4

  31. Bolli R (2017) Repeated cell therapy: a paradigm shift whose time has come. Circ Res 120:1072–1074

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Surgeon, Maharaja Agrasen Hospital, Siliguri, India

    Anjan Kumar Das

Authors
  1. Anjan Kumar Das
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anjan Kumar Das.

Ethics declarations

Conflict of Interest

The author declares no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Das, A.K. Current Status of Stem Cell Therapy in Heart Failure. Indian J Surg 85 (Suppl 2), 381–384 (2023). https://doi.org/10.1007/s12262-022-03426-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-022-03426-z

Keywords

Search

Navigation